Opinion

The launch of the Unified Patent Court today is the latest development in a revolutionary period that is only just getting started and from which there is no escape

01 June 2023

Saturday Opinion: EIP partner Andrew Thompson weighs in on the potential winners and losers

27 May 2023

World class strategic IP expertise is keeping things afloat in the face of daunting odds, but that cannot last forever

25 May 2023

Saturday Opinion: If the agency seeks to single out Unified Patents and bar it from filing IPRs, argues its GC Jonathan Stroud, it must also scrutinise the lack of transparency and conduct of prolific NPEs

20 May 2023

Last week’s completion of a $200 million deal with NPE Malikie Innovations Limited saw more valuable IP leave Canadian ownership and was for a much lower amount than CEO John Chen and his board had originally planned for

18 May 2023

Opinion: Pharma and biotech patent professionals must adapt to new challenges and opportunities

13 May 2023

In the 20 years IAM has been around, we have seen some brilliant individuals make a major difference to the companies that employ them. But they often leave a problem behind

11 May 2023

Saturday opinion: Recent dialogue about the US patent system mimics patent holders’ passion for  the virtuous cycle of innovation

06 May 2023

Fiery language aimed at patent holders by DG Grow chief Thierry Breton cannot mask the lack of evidence supporting the need for legislation

04 May 2023

Saturday Opinion: Discretionary denial of IPRs with co-pending litigation will benefit IP owners but some provisions contradict statutory authority

29 April 2023

Until policy makers in Washington DC fully recognise the extent of the self-harm that has been done to American interests, serious recovery is a forlorn hope

27 April 2023

Saturday Opinion: As ESTI and key US players move to intervene, the geopolitical ramifications of the proposal start to show

22 April 2023

With the European Commission increasingly ambivalent about patents, the UK has an opportunity to take leadership in areas such as SEP licensing and the life sciences

20 April 2023

If Chief Judge Colm Connolly starts to force plaintiffs to reveal their litigation financiers’ investors, there’s a risk funding will dry up for deserving patent holders

15 April 2023

In the US and Europe, immensely wealthy businesses that use technology created by others to drive their profits have succeeded in tilting the playing field in their favour

13 April 2023

SEP/FRAND is not the only area where the European Commission is set to propose changes that weaken the rights of innovators

08 April 2023

As things stand, the only winners from the proposals will be deep pocket implementers – but there may be a way out of the mess

06 April 2023

Plans for patent essentiality checking, patent counting and aggregate royalty apportionments at EUIPO disregard prevailing valuation benchmarks in numerous long-established comparable licences

05 April 2023

Following the leak of draft rules, IAM travelled to Brussels to gauge the reaction of industry, lobbyists and lawmakers

01 April 2023

Reported DG Grow proposals designed to make FRAND dealmaking in Europe more transparent, predictable and efficient are one-sided and poorly thought-through, so will do much more harm than good

30 March 2023